MedCity News
MAY 16, 2024
While adopting new technology is obviously a big part of healthcare innovation teams’ work, there are plenty of worthwhile initiatives that don’t involve advanced technologies, pointed out Dan Shoenthal, chief innovation officer at MD Anderson Cancer Center. The post Innovation Doesn’t Always Have To Involve The Latest Tech, MD Anderson Exec Says appeared first on MedCity News.
Fierce Pharma
MAY 16, 2024
The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. With 18 of the industry’s top 25 companies achieving year-over-year revenue gains, Q1 came close to matching the final quarter of last year, when 21 of the top 25 companies showed increases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MAY 16, 2024
The dangers of polypharmacy and its increasingly wide reach across the American population make it imperative that we enhance the accuracy and efficiency of medication reconciliation processes. The post It’s Past Time to Prevent Polypharmacy in U.S. Healthcare appeared first on MedCity News.
Fierce Pharma
MAY 16, 2024
China-made PD-1 inhibitors just can’t get a clean pass through the FDA. | China-made PD-1 inhibitors continue to struggle at the FDA. This week, the U.S. agency rejected Elevar Therapeutics and Jiangsu Hengrui Pharma's PD-1 combination in liver cancer.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
MAY 16, 2024
Johnson & Johnson’s Proteologix acquisition adds a pipeline of bispecific antibodies, including an experimental treatment for asthma and atopic dermatitis. It’s the latest M&A deal involving molecules addressing TSLP, a key signaling protein involved in inflammation. The post J&J Joins Chase for Hot Immunology Target With $850M Proteologix Acquisition appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MAY 16, 2024
Virginia Medicaid beneficiaries now have access to Aeroflow Health’s breast pumps and lactation consultants. The post Virginia Medicaid Taps Aeroflow Health for Lactation Services appeared first on MedCity News.
Fierce Pharma
MAY 16, 2024
Right on the heels of a similar move by Johnson & Johnson, GSK is offloading the rest of its stake in the consumer healthcare business it spun out back in 2022. | GSK plans to sell its remaining holding in consumer healthcare spinoff Haleon, the British drugmaker said Thursday. After prior divestments, GSK currently owns about 385 million Haleon shares.
MedCity News
MAY 16, 2024
At the MedCity INVEST conference from May 21-22 at the Ritz Carlton in Chicago, a panel discussion sponsored by Quantum Health will share how employers are addressing value-based care. The post Employers Will Share Value-Based Care Strategies at MedCity INVEST appeared first on MedCity News.
Fierce Pharma
MAY 16, 2024
After admitting to the crime four years ago, a former Sandoz executive will avoid hard time for his part in a generic drug price-fixing scheme. | Hector Kellum agreed to cooperate with federal investigators in 2020, admitting his part in a massive generics price-fixing scheme that spanned many companies.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaVoice
MAY 16, 2024
The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.
Fierce Pharma
MAY 16, 2024
The FDA has broadened the use of Bristol Myers Squibb’s CAR-T therapy Breyanzi to another type of blood cancer. | The FDA has broadened the use of Bristol Myers Squibb’s CAR-T therapy Breyanzi to another type of blood cancer, where the CD19 CAR-T will again compete with Gilead Sciences and Novartis drugs.
PharmaVoice
MAY 16, 2024
Execs from J&J, Novartis, Novo Nordisk and AbbVie sound off on the Inflation Reduction Act, supply issues and launch preparations in a tricky environment.
PharmaTimes
MAY 16, 2024
The OptiZest study aims to investigate a personalised dose of Zestril in these patients
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
pharmaphorum
MAY 16, 2024
Notable biotech financings in the last week include a $120m direct offering for iTeos, and private rounds for Lycia, Attovia, Ajax, and CinDome
PharmaTimes
MAY 16, 2024
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
pharmaphorum
MAY 16, 2024
Roche reports promising data with obesity candidate CT-388, bought as part of its $3.
Pharmaceutical Technology
MAY 16, 2024
The US National Opioid Settlement is distributing more than $54 billion to communities grappling with the opioid crisis.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Commerce
MAY 16, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
MAY 16, 2024
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Melanoma.
Copyright Clearance Center
MAY 16, 2024
May 16, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, was named a Bronze Stevie® Award winner for Customer Service Department of the Year in the 22nd annual American Business Awards ®. The American Business Awards are the premier business awards program in the U.S. Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries.
Pharmaceutical Technology
MAY 16, 2024
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmacy Times
MAY 16, 2024
Scott Soefje highlights how oncology pharmacists can advance patient-centered care and drive innovation in clinical research.
Pharmaceutical Technology
MAY 16, 2024
INZ-701 is under clinical development by Inozyme Pharma and currently in Phase II for Pseudoxanthoma Elasticum (PXE or Gronblad Strandberg Syndrome).
Pharmacy Times
MAY 16, 2024
Hepatitis Awareness Month is designed to raise awareness of viral hepatitis and promote testing and vaccination while decreasing the stigma against the virus.
Pharmaceutical Technology
MAY 16, 2024
IgGenix is planning to initiate a clinical trial later this year investigating its peanut allergy monoclonal antibody IGXN001.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmacy Times
MAY 16, 2024
As Summer Approaches, Many Will Be Planning Vacations and Trips Abroad
Pharmaceutical Technology
MAY 16, 2024
Takeda's new dengue vaccine, TAK-003, has received prequalification from the World Health Organization (WHO).
Clarify Health
MAY 16, 2024
Chief Strategy Officers (CSOs) for health systems face the constant challenge of finding new revenue streams to cover the increasing costs of high- quality healthcare. To help tackle the problem, they are turning to predictive analytics for deep insights that can drive strategic decisions and open new revenue channels. By leveraging predictive analytics, CSOs can identify under-served areas, develop new service lines, enhance telemedicine offerings, and foster partnerships and collaborative ve
Expert insights. Personalized for you.
341 
Let's personalize your content